Pulmonary tuberculosis due to Mycobacterium microti: a study of six recent cases in France
Author(s) -
G. Panteix,
M. Cristina Gutiérrez,
María Laura Boschiroli,
M-S. Rouvière,
A. Plaidy,
D. Pressac,
H. Porcheret,
Georges Chyderiotis,
Mikael Ponsada,
K. Van Oortegem,
S. Salloum,
S. Cabuzel,
AnneLaure Bañuls,
Philippe Van de Perre,
Sylvain Godreuil
Publication year - 2010
Publication title -
journal of medical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.91
H-Index - 117
eISSN - 1473-5644
pISSN - 0022-2615
DOI - 10.1099/jmm.0.019372-0
Subject(s) - tuberculosis , medicine , pulmonary tuberculosis , mycobacterium tuberculosis , disease , clinical significance , university hospital , pathology
Human tuberculosis caused by Mycobacterium microti is rare, but its prevalence and clinical significance may have been underestimated. To the best of our knowledge, 21 cases have been reported in the literature in the last decade. We report six recent pulmonary cases caused by M. microti over a period of 5 years detected in French clinical mycobacteriology laboratories of the hospital network. Our data confirm the potential of M. microti to cause clinical illness in immunocompetent patients. M. microti grew slowly from specimens, delaying the final microbiological diagnosis. Therefore, patients with tuberculosis caused by M. microti could benefit from the use of rapid diagnostic molecular techniques directly on clinical samples. From a review of the literature and this study, a classical antituberculous therapy seems effective in treating patients with M. microti disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom